NCT04508153已完成不适用
A Prospective Randomized Trial Comparing Efficacy of Pelvic Floor Muscle Training With a Digital Therapeutic Device to Standard Exercises for the Treatment of Stress Urinary Incontinence: A Remote Digital Trial
Renovia, Inc.6 个研究点 分布在 1 个国家目标入组 369 人开始时间: 2020年10月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 369
- 试验地点
- 6
- 主要终点
- Efficacy - Urogenital Distress Inventory (UDI-6)
研究概览
简要总结
A virtual prospective randomized controlled study to evaluate the efficacy of using the leva® Pelvic Digital Health System (PDHS) to perform PFMT compared to a standard home exercise home program for the treatment of SUI/SMUI. The treatment part of the study lasts eight weeks and has two arms. One group will receive routine care consisting of at-home Kegel exercises, and the other will be provided with a leva® device and instructions for use. Subjects in both groups will be assessed at baseline, then at 4 and 8 weeks for change and improvement of their symptoms. They will also be assessed at 6 and12 months after study completion.
详细描述
This trial is entirely virtual. No office visits, specific locations, or physical examination will be required. Enrollment may occur from any location in the United States
- A virtual prospective randomized controlled study to evaluate the efficacy of using the leva® PDHS to perform PFMT (leva arm) compared to standard care of a PFM exercise home program (Kegel arm) for the treatment of SUI or SMUI.
- Following completion of e-consent and screening, including an initial bladder diary and introductory phone call to review the study requirements, subjects are considered officially enrolled.
- A series of baseline assessments will be administered to all subjects to evaluate symptom severity, frequency and impact.
- Subjects will then be randomized to either the leva® arm or Kegel arm on a 1 to 1 ratio using block randomization. Prior to initiation of the trial, a randomization sequence will be generated by the ObvioHealth system. Participants will be automatically allocated the next available slot in the sequence at the time of their randomization and assigned to the leva® or Kegel group accordingly.
- Prior to beginning the program, subjects in the Kegel arm will receive printed instructions for PFMT with Kegel exercises. Subjects in the leva® arm will be shipped the leva® digital device, along with instructions for use and how to download the corresponding digital app. Day 1 of the study begins the day following receipt of materials.
- Study population: women with SUI or SMUI.
- The study requires no office visits. All participant data will be entered in the subject's smartphone using a custom designed mobile application. Participants will be able to interact with the app throughout the study period and will be presented with surveys and a voiding diary on a specified schedule during an 8-week treatment period. There will also be expected post-intervention follow up surveys at 6- and 12-months
- Using virtual recruiting, a total of up to 350 subjects will be enrolled in the trial.
- Subjects in both arms will have three scheduled phone calls with study staff during the first two weeks of treatment.
- Subjects can speak to the study staff at any time via an in-app chat function, the phone, or videoconference.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Investigator, Outcomes Assessor)
盲法说明
Subjects will be randomized to either the leva® arm or Kegel arm on a 1 to 1 ratio using block randomization. Prior to initiation of the trial, a randomization sequence will be generated by the ObvioHealth system. Participants will be automatically allocated the next available slot in the sequence at the time of their randomization and assigned to the leva® or Kegel group accordingly
入排标准
- 年龄范围
- 18 Years 至 100 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •≥18 years of age
- •Capable of giving informed consent
- •Possess a smartphone capable of interacting with the ObvioHealth and Renovia apps
- •Self-reported SUI/SMUI symptoms of ≥ three months duration
- •Diagnosis SMUI based on Medical, Epidemiologic and Social Aspects of Aging (MESA) stress symptom score (Percent of total possible stress score) greater than MESA urge symptom score (percent of total possible urge score)
- •English speaking
- •Postmenopausal, post hysterectomy, or willing to use an acceptable method of birth control for the duration of the study
- •Able to complete a bladder diary using the ObvioHealth app
- •Able to complete electronic surveys and upload data
- •Willing to provide contact information and respond to remote contact: phone calls, text messages, email
- •Willing to participate in the 8-week study with follow up at 6-and 12-months, refraining from the pursuit of treatment for Stress UI using other modalities (i.e. will not wear a pessary, participate in pelvic floor Physical Therapy or surgery) during the first 8 weeks
排除标准
- •Absence of a vagina, per patient report
- •Reports seeing or feeling a vaginal bulge or sensation of vaginal bulge
- •Diagnosis of any neuromuscular disease that may contribute to UI (i.e., multiple sclerosis, spinal cord injury, Parkinson's Disease, etc.)
- •Non-ambulatory, per patient report
- •Currently pregnant or <6 months post-partum per patient report
- •Currently (or within the last 1 month) breast feeding
- •Prior surgery for stress UI
- •Previous PFMT: 2 visits within the last 3 months under a supervised therapeutic plan of care
- •Currently taking, or has taken within the last 2 months, medication to treat UI
- •Prior augmentation cystoplasty or artificial sphincter
- •Implanted nerve stimulator for urinary symptoms, active within the past 60 days
- •Participation in another clinical study within 30 days of screening
- •Impaired cognitive function per patient report and evaluation of medication list
- •Contraindication to the use of a vaginal probe
- •Unable to understand instructions on the use of the leva® PDHS
- •Unable to operate a smartphone app with use of Bluetooth and Wi-Fi connectivity
结局指标
主要结局
Efficacy - Urogenital Distress Inventory (UDI-6)
时间窗: Baseline, 4 weeks, 8 weeks, 6 months and 12 months
UDI-6 is a validated questionnaire assessing symptom presence and degree of bother. It will be used to compare the degree of symptom change in the leva arm vs the Kegel arm within and between groups.
Efficacy - Bladder diaries
时间窗: Baseline and 8 weeks
Bladder diaries evaluating the average number of stress-incontinence episodes in 3 days will be compared within and between groups
次要结局
- Survey evaluations of incontinence Pelvic Organ Prolapse Distress Inventory (POPDI-6)(Baseline, 4 weeks, 8 weeks, 6 months and 12 months)
- Patient Reported perception of general health Short Form-20 (SF-20)(Baseline, 4 weeks, 8 weeks, 6 months and 12 months)
- Self-reported adherence(4 weeks, 8 weeks)
- Correlations between self-reported adherence and device reported adherence in the leva group(4 weeks, 8 weeks)
- Incidence of Treatment-Emergent Adverse Events (Safety and tolerability)(Through study completion, an average of 1 year)
- Survey evaluations of incontinence Colorectal-Anal Distress Inventory-8 (CRADI-8)(Baseline, 4 weeks, 8 weeks, 6 months and 12 months)
- Survey evaluations of incontinence Pelvic Floor Distress Inventory (PFDI-20)(Baseline, 4 weeks, 8 weeks, 6 months and 12 months)
- Survey evaluations of incontinence Patient Global Impression of Severity (PGI-S)(Baseline, 4 weeks, 8 weeks, 6 months and 12 months)
- Feedback on perception of treatment - likelihood of recommending to a friend(4 weeks, 8 weeks)
- Feedback on perception of treatment - interest in surgical treatment(4 weeks, 8 weeks)
- Survey evaluations of incontinence Patient Global Impression of Improvement (PGI-I)(4 weeks, 8 weeks, 6 months and 12 months)
- Survey evaluations of incontinence Pelvic Floor Impact Questionnaire (PFIQ)(Baseline, 4 weeks, 8 weeks, 6 months and 12 months)
- Survey evaluations of incontinence Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-IR)(Baseline, 4 weeks, 8 weeks, 6 months and 12 months)
研究者
研究点 (6)
Loading locations...
相似试验
已完成
不适用
The Effects of Lutein and Zeaxanthin Supplementation on Vision in Patients With AlbinismOcular Albinism (OA)Oculocutaneous Albinism (OCA)NCT02200263Johns Hopkins University10
已完成
不适用
Effectiveness of Virtual Reality Psychotherapy and Yoga on Student Performance AnxietyPerformance AnxietyNCT06639841Grigore T. Popa University of Medicine and Pharmacy55
暂停
不适用
A trial comparing efficacy, safety and tolerance between Levetiracetam and Valproic acid in children with epilepsy.epilepsyNL-OMON24550Prof.dr. O.F. Brouwer200
终止
2 期
Trial of Lovaza in Adolescents With Mild to Moderately Elevated TriglyceridesHypertriglyceridemiaNCT00672633Boston Children's Hospital25
Unknown
不适用
Erb:Yag Laser Versus Pelvic Floor Training for the Treatment of Women With Mild to Moderate Stress Urinary IncontinenceStress Urinary IncontinenceNCT04705285Pontificia Universidad Catolica de Chile60